Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition
9 May 2026 – 14 May 2026 · Cape Town, South Africa
504-02-007 ISMRM Abstract

Transcriptional and Neurotransmitter Signatures of Increased Brain Free Water in Parkinson’s Disease

Primary: Neuro - Parkinson's Disease
Secondary: Diffusion - Microstructure
504-02-007 · Probing Brain Microstructure with Water: Applications · Wednesday, 13 May, 8:20 AM–10:10 AM · Ballroom East
Keywords: Parkinson's Disease Free water Gamma-aminobutyric acid Imaging transcriptomics Neurotransmitter mapping
Accepted
Dongling Zhang1,2, Junye Yao 3, Lingyan Ma4, Tao Feng4, Hongjian HE5,6, Tao Wu1,2,4
1Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
2China National Clinical Research Center for Neurological Diseases, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
3Clinical & Technical Support, Philips Healthcare, Guangzhou, China
4Center for Movement Disorders, Department of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
5School of Physics, Zhejiang University, Hangzhou, China
6State Key Laboratory of Brain-Machine Intelligence, Zhejiang University, Hangzhou, China
Presenting Author: Junye Yao

Synopsis

Motivation:
Goals:
Approach:
Results:
Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

Log in

References

1. Pasternak O, Sochen N, Gur Y, Intrator N, Assaf Y. Free water elimination and mapping from diffusion MRI. Magn Reson Med 2009;62:717–730. doi: 10.1002/mrm.22055. [doi]
2. Albi A, Pasternak O, Minati L, et al. Free water elimination improves test-retest reproducibility of diffusion tensor imaging indices in the brain. Hum Brain Mapp 2017;38:12–26. doi: 10.1002/hbm.23350. [doi]
3. Andica C, Kamagata K, Hatano T, et al. Free-Water Imaging in White and Gray Matter in Parkinson's Disease. Cells 2019;8:839. doi: 10.3390/cells8080839. [doi]
4. Burciu RG, Ofori E, Archer DB, et al. Progression marker of Parkinson's disease: a 4-year multi-site imaging study. Brain 2017;140:2183-2192. doi: 10.1093/brain/awx146. [doi]
5. Hawrylycz MJ, Lein ES, et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature 2012;489:391–399. doi: 10.1038/nature11405. [doi]
6. Arnatkeviciute A, Markello RD, Fulcher BD, Misic B, Fornito A. Toward Best Practices for Imaging Transcriptomics of the Human Brain. Biol Psychiatry 2023;93:391–404. doi: 10.1016/j.biopsych.2022.10.016. [doi]
7. Thomas GEC, Zarkali A, Ryten M, et al. Regional brain iron and gene expression provide insights into neurodegeneration in Parkinson’s disease. Brain 2021;144:1787–1798. doi: 10.1093/brain/awab084. [doi]
8. Eshaghzadeh Torbati M, Minhas DS, Ahmad G, et al. A multi-scanner neuroimaging data harmonization using RAVEL and ComBat. Neuroimage 2021;245:118703. doi: 10.1016/j.neuroimage.2021.118703. [doi]
9. Raudvere U, Kolberg L, Kuzmin I, et al. g:Profiler: a web server for functional enrichment analysis. Nucleic Acids Res 2019;47:W191–W198. doi: 10.1093/nar/gkz369. [doi]
10. Dukart J, Holiga S, Rullmann M, et al. JuSpace: A tool for spatial correlation analyses of MRI data with neurotransmitter maps. Hum Brain Mapp 2020;42:555–566.
11. Tagliaferro P, Burke RE. Retrograde Axonal Degeneration in Parkinson Disease. J Parkinsons Dis 2016;6:1-15. doi: 10.3233/JPD-150769. [doi]
12. Wang J, Wang F, Mai D, Qu S. Molecular Mechanisms of Glutamate Toxicity in Parkinson’s Disease. Frontiers in Neuroscience 2020;14. doi: 10.3389/fnins.2020.585584. [doi]
13. Smith-Hicks CL. GABAergic dysfunction in pediatric neuro-developmental disorders. Frontiers in Cellular Neuroscience 2013; 7:269. doi: 10.3389/fncel.2013.00269. [doi]
14. van Nuland AJM, den Ouden HEM, Zach H, et al. GABAergic changes in the thalamocortical circuit in Parkinson's disease. Human Brain Mapping 2019;41:1017-1029. doi: 10.1002/hbm.24857. [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/504-02-007